Case Study: Phase III AAD Trial

Phase III AAD Trial

A large, global sponsor was experiencing difficulties in hitting enrollment numbers for an Agitation in Alzheimer's Dementia trial. Having closed many sites due to slow enrollment, the study team needed help in identifying experienced sites with access to their target patient population.

The sponsor collaborated with Inato to access untapped patient populations and identify qualified sites that could enroll patients in just two months. Discover how partnering with Inato allowed them to meet their trial goals and accelerate their timeline.